# US 2019/0167621 A1 · Solution for ophthalmology

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0167621 A1
- Document ID: US20190167621A1
- Status: Published application
- Kind: A1
- Application number: 16/268,156
- Filed: 2019-02-05
- Published: 2019-06-06
- Earliest claimed: 2016-06-03
- Assignees: Joerg H. Krumeich
- Inventors: Joerg H. KRUMEICH; Gerrit NATTLER
- Web page: https://patentgrep.com/patent/US20190167621A1

## CPC

- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61K 9/0051: {Ocular inserts or implants}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The invention relates to a solution for lysis of particles and fibers that adhere to a lens capsule of the eye during cataract operations, which solution contains 0.5-3.5 wt.-% lysine, particularly L-lysine, in an isotonic to hypertronic aqueous solution.

## Claims

### Claim at position 1

1-12. (canceled)

### Claim 13

A method for facilitating removal of lens cortex tissue from a lens capsule of an eye of a patient during a cataract operation, the method comprising:
applying a solution containing 0.5-3.5 wt.-% lysine in an isotonic to hypertonic aqueous solution to the lens capsule during the cataract operation; and
aspirating the lens cortex tissue and solution from the lens capsule.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the lysine is present in the form of a physiologically tolerated salt.

### Claim 15 (depends on 13)

The method according to claim 13, wherein the solution contains 1-3 wt.-% lysine hydrochloride.

### Claim 16 (depends on 13)

The method according to claim 13, wherein the solution is a saline solution.

### Claim 17 (depends on 13)

The method according to claim 13, wherein the osmolarity of the solution corresponds to that of a 0.9-1.7% saline solution.

### Claim 18 (depends on 13)

The method according to claims 13, wherein the solution has a pH of 6-8.

### Claim 19 (depends on 13)

The method according to claim 13, wherein the solution is viscoelastic.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the solution contains a polysaccharide.

### Claim 21 (depends on 13)

The method according to claim 13, wherein epithelial cells and protein components are also removed from the lens capsule.

### Claim 22 (depends on 13)

The method according to claim 13, wherein said method achieves prophylaxis of capsular fibrosis.

### Claim 23 (depends on 13)

The method according to claim 13, wherein the lysine is L-lyisne.

### Claim 24 (depends on 13)

The method according to claim 13, wherein the lens tissue and solution are aspirated from the lens capsule between 30 seconds and 3 minutes after application of the solution to the lens capsule.

### Claim 25

A method for preventing capsule fibrosis or secondary cataract in a lens capsule after a cataract operation, the method comprising:
applying a solution containing 0.5-3.5 wt.-% lysine in an isotonic to hypertonic aqueous solution to the lens capsule during the cataract operation; and
aspirating the solution from the lens capsule.

### Claim 26 (depends on 25)

The method according to claim 25, wherein the lysine is present in the form of a physiologically tolerated salt.

### Claim 27 (depends on 25)

The method according to claim 25, wherein the solution contains 1-3 wt.-% lysine hydrochloride.
